Japan’s largest drugmaker Takeda has announced new data from VERDICT showing that treating adults with intravenous Entyvio ...
South Korea’s Samsung Bioepis announced a landmark 10-year agreement with its local partners in Brazil - state-level public ...
Australian biotech Starpharma saw its shares tumble 33% to A$0.50 today, after announcing that it has increased its equity ...
US biotech company TriGemX Bio has agreed to go public through a merger expected to generate about $246 million in gross ...
The US Food and Drug Administration has granted accelerated approval for a new use of the immunotherapy Jemperli (dostarlimab ...
US drugmaker Collegium Pharmaceuticals announced a settlement agreement between the company and Germany’s Grunenthal.
German biotech Repairon, which is developing regenerative cardiac therapies, today announced the appointment of Detlef ...
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has authorized Redemplo (plozasiran) to reduce ...
US biotech major Amgen and the UK’s AstraZeneca today announced full results from the Phase III CROSSING trial of Tezspire ...
US pharma major Eli Lilly (NYSE: LLY) has partnered with Chinese biotech company METiS TechBio (HKEX: 7666) to develop lipid nanoparticles (LNPs) that could deliver medicines more precisely to ...
Scenic Biotech is preparing to take its lead program, SC6177, into clinical development in 2027. The Pharma Letter speaks ...
China's Hansoh Pharma has signed a strategic collaboration and license agreement with Swiss pharma giant Roche to develop a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results